PLK3 Protein (AA 1-646) (GST tag)
-
- Target Alle PLK3 Proteine anzeigen
- PLK3 (Polo-Like Kinase 3 (PLK3))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 1-646
-
Spezies
- Human
-
Quelle
- Wheat germ
- Aufreinigungstag / Konjugat
- Dieses PLK3 Protein ist gelabelt mit GST tag.
- Applikation
- ELISA, Western Blotting (WB), Affinity Purification (AP), Antibody Array (AA)
- Verwendungszweck
- PLK3 (Human) Recombinant Protein (P01)
- Sequenz
- MEPAAGFLSP RPFQRAAAAP APPAGPGPPP SALRGPELEM LAGLPTSDPG RLITDPRSGR TYLKGRLLGK GGFARCYEAT DTETGSAYAV KVIPQSRVAK PHQREKILNE IELHRDLQHR HIVRFSHHFE DADNIYIFLE LCSRKSLAHI WKARHTLLEP EVRYYLRQIL SGLKYLHQRG ILHRDLKLGN FFITENMELK VGDFGLAARL EPPEQRKKTI CGTPNYVAPE VLLRQGHGPE ADVWSLGCVM YTLLCGSPPF ETADLKETYR CIKQVHYTLP ASLSLPARQL LAAILRASPR DRPSIDQILR HDFFTKGYTP DRLPISSCVT VPDLTPPNPA RSLFAKVTKS LFGRKKKSKN HAQERDEVSG LVSGLMRTSV GHQDARPEAP AASGPAPVSL VETAPEDSSP RGTLASSGDG FEEGLTVATV VESALCALRN CIAFMPPAEQ NPAPLAQPEP LVWVSKWVDY SNKFGFGYQL SSRRVAVLFN DGTHMALSAN RKTVHYNPTS TKHFSFSVGA VPRALQPQLG ILRYFASYME QHLMKGGDLP SVEEVEVPAP PLLLQWVKTD QALLMLFSDG TVQVNFYGDH TKLILSGWEP LLVTFVARNR SACTYLASHL RQLGCSPDLR QRLRYALRLL RDRSPA
- Produktmerkmale
- Human PLK3 full-length ORF ( NP_004064.2, 1 a.a. - 646 a.a.) recombinant protein with GST-tag at N-terminal.
- Aufreinigung
- in vitro wheat germ expression system
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Preparation method: in vitro, wheat germ expression system
Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Best use within three months from the date of receipt of this protein.
-
-
Design, synthesis, and evaluation of non-ATP-competitive small-molecule Polo-like kinase 1 (Plk1) inhibitors." in: Archiv der Pharmazie, Vol. 348, Issue 1, pp. 2-9, (2015) (PubMed).
: "
-
Design, synthesis, and evaluation of non-ATP-competitive small-molecule Polo-like kinase 1 (Plk1) inhibitors." in: Archiv der Pharmazie, Vol. 348, Issue 1, pp. 2-9, (2015) (PubMed).
-
- Target
- PLK3 (Polo-Like Kinase 3 (PLK3))
- Andere Bezeichnung
- PLK3 (PLK3 Produkte)
- Synonyme
- cnk Protein, wu:fi35f10 Protein, fnk Protein, prk Protein, plx3 Protein, MGC89507 Protein, PLK2/3 Protein, NV15469 Protein, Plx3 Protein, CNK Protein, FNK Protein, PRK Protein, Cnk Protein, Fnk Protein, polo-like kinase 3 (Drosophila) Protein, polo like kinase 3 Protein, polo-like kinase 3 Protein, polo-like kinase 3 S homeolog Protein, polo-like kinase 3 L homeolog Protein, Serine/threonine-protein kinase plk-3 Protein, plk3 Protein, PLK3 Protein, LOC100118436 Protein, plk3.S Protein, plk3.L Protein, Plk3 Protein, plk-3 Protein
- Hintergrund
-
Full Gene Name: polo-like kinase 3 (Drosophila)
Synonyms: CNK,FNK,PRK - Gen-ID
- 1263
- NCBI Accession
- NM_004073
- Pathways
- Regulation of long-term Neuronal Synaptic Plasticity
-